Mandate

Vinge advises Capio in connection with acquisition of Backa Läkarhus

January 05, 2017

The operations had a turnover of approximately MSEK 345 in 2016, and have 83 000 listed patients. Closing is subject to customary closing conditions from the relevant county councils and unconditional approval from the Swedish Competition Authority. The enterprise value amounts to MSEK 300.

Vinge’s team primarily consists of client responsible partner Anders Strid, Frida Bäckegren (project leader M&A), Lina André and Jonas Lindblad (employment), Gabriella Fossum (procurement), Mercedes Anderås (real estate), Camilla Andersson (corporate) as well as Pär Remnelid, among others (competition).

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026